The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Undercarboxylated Osteocalcin Measured with a Specific Immunoassay Predicts Hip Fracture in Elderly Women: The EPIDOS Study1
Abstract
Increased levels of circulating undercarboxylated osteocalcin (ucOC), measured indirectly with the hydroxyapatite (HAP) binding assay, have been shown to predict hip fracture risk in a small group of elderly institutionalized women. The aim of this study was to confirm these findings in a prospective cohort study (EPIDOS prospective study) of 7598 healthy, independently living women over 75 yr of age. One hundred and four women who sustained a hip fracture during a 22-month follow-up period were age matched with 255 controls who did not fracture. Baseline samples were collected before hip fracture for measurement of total OC and ucOC, assessed either with the HAP binding assay or directly with a new enzyme-linked immunosorbent assay (ELISA). This direct ELISA uses human recombinant noncarboxylated OC as a standard and two monoclonal antibodies, one of which was raised against the 14-30 Glu synthetic peptide. We found that the intra- and interassay variations are less than 11%, and this assay exhibits a 5% cross-reactivity with purified human bone OC, used as a source of carboxylated OC. ucOC levels measured with this ELISA correlated well with the HAP binding assay in the population of 359 elderly women (r = 0.82; P < 0.0001). We estimated the risk of hip fracture for women with levels of ucOC in the highest quartile of values for the 255 controls. We found that increased levels of ucOC measured by ELISA were associated with increased hip fracture risk with an odds ratio (OR) of 1.9 (95% confidence interval, 1.2-3.0), and the ELISA had a greater sensitivity than the HAP assay. In contrast, total OC was not associated with hip fracture risk. After adjustment for femoral neck bone mineral density (BMD) and mobility status assessed by gait speed, ucOC still predicted hip fracture with an OR of 1.8 (1.0-3.0). Women with both femoral neck BMD in the lowest quartile and ucOC in the highest quartile were at higher risk of hip fracture, with an OR of 5.5 (2.7-11.2), than those with only low BMD or high ucOC levels. In conclusion, we have developed a new specific ELISA for serum ucOC, with low cross-reactivity with carboxylated OC and increased specificity and sensitivity over the HAP assay. Using this new ELISA, we found that ucOC, but not total OC, predicts hip fracture risk independently of femoral neck BMD in elderly women drawn from the general population. Thus, ucOC measurement could be combined with bone mass determination to improve the assessment of hip fracture risk in elderly women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Risk Factors for Hip Fracture in White Women
Cummings, S. R., Nevitt, M. C., Browner, W. S., Stone, K., Fox, K. M., Ensrud, K. E., Cauley, J., Black, D., & Vogt, T. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503233321202 · Cited by 3,595
Vitamin D3and Calcium to Prevent Hip Fractures in Elderly Women
Chapuy, M. C., Arlot, M. E., Duboeuf, F., Brun, J., Crouzet, B., Arnaud, S., Delmas, P. D., & Meunier, P. J. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212033272305 · Cited by 2,950
Self-citationIncreased bone formation in osteocalcin-deficient mice
Ducy, P., Desbois, C., Boyce, B., Pinero, G., Story, B., Dunstan, C., Smith, E., Bonadio, J., Goldstein, S., Gundberg, C., et al. (1996) · Nature · doi:10.1038/382448a0 · Cited by 1,725
Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone
Hauschka, P. V., Lian, J. B., Cole, D. E., & Gundberg, C. M. (1989) · Physiological Reviews · doi:10.1152/physrev.1989.69.3.990 · Cited by 1,272
Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study
Garnero, P., Hausherr, E., Chapuy, M.-C., Marcelli, C., Grandjean, H., Muller, C., Cormier, C., Bréart, G., Meunier, P. J., & Dr. Delmas, P. D. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650111021 · Cited by 989
Self-citationFall-related factors and risk of hip fracture: the EPIDOS prospective study
Dargent-Molina, P., Favier, F., Grandjean, H., Baudoin, C., Schott, A., Hausherr, E., Meunier, P., & Bréart, G. (1996) · The Lancet · doi:10.1016/s0140-6736(96)01440-7 · Cited by 901
Self-citationLong-term fracture prediction by bone mineral assessed at different skeletal sites
Dr. Melton, L. J., Atkinson, E. J., O'Fallon, W. M., Wahner, H. W., & Riggs, B. L. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650081010 · Cited by 862
Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone.
Price, P. A., Williamson, M. K., & Lothringer, J. W. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42960-2 · Cited by 485
Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women.
Szulc, P., Chapuy, M. C., Meunier, P. J., & Delmas, P. D. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116387 · Cited by 484
Self-citationStructure of the rat osteocalcin gene and regulation of vitamin D-dependent expression.
Lian, J., Stewart, C., Puchacz, E., Mackowiak, S., Shalhoub, V, Collart, D., Zambetti, G., & Stein, G. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.4.1143 · Cited by 368
Cited by
for the IOF-IFCC Bone Marker Standards Working Group, Vasikaran, S., Eastell, R., Bruyère, O., Foldes, A. J., Garnero, P., Griesmacher, A., McClung, M., Morris, H. A., Silverman, S., et al. (2011) · Osteoporosis International · doi:10.1007/s00198-010-1501-1 · Cited by 1,212
Self-citationPosition of the American Dietetic Association: Vegetarian Diets
(2009) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2009.05.027 · Cited by 1,035
Craig, W. J. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.26736n · Cited by 597
Nutrition in Bone Health Revisited: A Story Beyond Calcium
Ilich, J. Z., & Kerstetter, J. E. (2000) · Journal of the American College of Nutrition · doi:10.1080/07315724.2000.10718070 · Cited by 509
Vitamin K intake and hip fractures in women: a prospective study
Feskanich, D., Weber, P., Willett, W. C., Rockett, H., Booth, S. L., & Colditz, G. A. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/69.1.74 · Cited by 484
Shiraki, M., Shiraki, Y., Aoki, C., & Miura, M. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.3.515 · Cited by 408
Booth, S. L., Tucker, K. L., Chen, H., Hannan, M. T., Gagnon, D. R., Cupples, L. A., Wilson, P. W., Ordovas, J., Schaefer, E. J., Dawson-Hughes, B., et al. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.5.1201 · Cited by 406
Bone Turnover Markers: Basic Biology to Clinical Applications
Schini, M., Vilaca, T., Gossiel, F., Salam, S., & Eastell, R. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnac031 · Cited by 387
Vasikaran, S., Cooper, C., Eastell, R., Griesmacher, A., Morris, H. A., Trenti, T., & Kanis, J. A. (2011) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2011.602 · Cited by 380
Nutrition concerns and health effects of vegetarian diets
Craig, W. J. (2010) · Nutrition in Clinical Practice · doi:10.1177/0884533610385707 · Cited by 370
Osteoporosis: the role of micronutrients
Nieves, J. W. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.5.1232 · Cited by 343
Bone turnover markers: Emerging tool in the management of osteoporosis
Shetty, S., Kapoor, N., Bondu, J. D., Thomas, N., & Paul, T. V. (2016) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.192914 · Cited by 330
“[14] Being a late marker of osteoblastic activity, it has been used as a bone formation marker but is limited by its short half-life, unstable intact molecule, and the influence of Vitamin K status, renal function, and circadian rhythm.”
BackgroundClinical Utility of Biochemical Markers of Bone Remodeling
Watts, N. B. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.8.1359 · Cited by 336
Osteocalcin: Skeletal and extra‐skeletal effects
Neve, A., Corrado, A., & Cantatore, F. P. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24278 · Cited by 335
The role of menaquinones (vitamin K2) in human health
Beulens, J. W. J., Booth, S. L., van den Heuvel, E. G. H. M., Stoecklin, E., Baka, A., & Vermeer, C. (2013) · British Journal of Nutrition · doi:10.1017/s0007114513001013 · Cited by 318
Lee, A. J., Hodges, S., & Eastell, R. (2000) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/000456320003700402 · Cited by 295
Diet, Nutrition, and Bone Health
Cashman, K. D. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.11.2507s · Cited by 286
Biochemical Markers of Bone Metabolism and Prediction of Fracture in Elderly Women
Gerdhem, P., Ivaska, K. K., Alatalo, S. L., Halleen, J. M., Hellman, J., Isaksson, A., Pettersson, K., Väänänen, H. K., Åkesson, K., & Obrant, K. J. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0301244 · Cited by 283
Bone turnover markers: use in osteoporosis
Naylor, K., & Eastell, R. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.86 · Cited by 262
Roles for Vitamin K Beyond Coagulation
Booth, S. L. (2009) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-080508-141217 · Cited by 256
Binkley, N., Harke, J., Krueger, D., Engelke, J., Vallarta-Ast, N., Gemar, D., Checovich, M., Chappell, R., & Suttie, J. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081254 · Cited by 163
Osteoporosis prevention and nutrition
Tucker, K. L. (2009) · Current Osteoporosis Reports · doi:10.1007/s11914-009-0020-5 · Cited by 151
“If γ-carboxylation is impaired, undercarboxylated osteocalcin accumulates, and the latter has been associated with increased risk of hip fracture [ 24 ].”
BackgroundCaillot-Augusseau, A., Vico, L., Heer, M., Voroviev, D., Souberbielle, J.-C., Zitterman, A., Alexandre, C., & Lafage-Proust, M.-H. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.8.1136 · Cited by 133
“Uoc measurements were performed using the HAP binding assay ( 11 ). Serum (250 mL) was extracted with 7 mg of HAP (tribasic calcium phosphate; Sigma) in an Eppendorf tube, mixed end over end for 1 h, and then centrifuged (1250g for 15 min at 4 °C).”
BackgroundMethodInfluentialInterventions to prevent bone loss in astronauts during space flight
Iwamoto, J., Takeda, T., & Sato, Y. (2005) · The Keio Journal of Medicine · doi:10.2302/kjm.54.55 · Cited by 114
Emaus, N., Gjesdal, C. G., Almås, B., Christensen, M., Grimsgaard, A. S., Berntsen, G. K. R., Salomonsen, L., & Fønnebø, V. (2010) · Osteoporosis International · doi:10.1007/s00198-009-1126-4 · Cited by 102
Sato, Y., Honda, Y., Kaji, M., Asoh, T., Hosokawa, K., Kondo, I., & Satoh, K. (2002) · Bone · doi:10.1016/s8756-3282(02)00783-4 · Cited by 76
RetractedSato, Y., Kanoko, T., Satoh, K., & Iwamoto, J. (2005) · Bone · doi:10.1016/j.bone.2004.09.018 · Cited by 59
RetractedShiraki, M., & Itabashi, A. (2009) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-008-0034-6 · Cited by 40
“In order to assess the effect of menatetrenone on osteocalcin metabolism, the serum levels of osteocalcin containing gamma carboxylated glutamic acid (Gla-OC), glutamic acid-containing osteocalcin (undercarboxylated osteocalcin, uc-OC), and intact osteocalcin (i-OC) were measured by a specific radioimmunoassay for Gla…”
MethodEmaus, N., Nguyen, N. D., Almaas, B., Berntsen, G. K., Center, J. R., Christensen, M., Gjesdal, C. G., Grimsgaard, A. S., Nguyen, T. V., Salomonsen, L., et al. (2013) · European Journal of Nutrition · doi:10.1007/s00394-011-0285-1 · Cited by 15
Metadata
- Authors
- Vergnaud, P., Garnero, P., Meunier, P. J., Bréart, G., Kamihagi, K., & Delmas, P. D.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1997-03-01
- Volume
- 82
- Issue
- 3
- Pages
- 719-724
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2045737960
- Cited by
- 389
- References
- 31
- FWCI
- 13.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.